Highbridge Capital Management’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q3
Sell
-20,869
Closed -$142K 1278
2013
Q2
$142K Buy
+20,869
New +$142K ﹤0.01% 862